Sunscreen is invisible in ordinary light. UV photography is the only reason you can see exactly where it was applied here.
Andrew Steele
Illustrative: a public science demonstration, not a photograph from this trial.
An Antioxidant Sunscreen Preserved Skin's Mitochondrial DNA in the First Human Trial, Though the Main Result Just Missed Significance
Every sunscreen, however high the SPF, still lets some visible light, infrared light and pollution through, and all of that can generate free radicals in skin the way UV rays do. The idea that adding antioxidants could mop up what the UV filters miss has been around for two decades, but almost all of the evidence for it came from cell cultures and lab grown skin models rather than real, living skin.
- A 12 week randomized, double blind, UK trial tested an encapsulated SPF 50 sunscreen with added antioxidants (resveratrol, glabridin, astaxanthin and ubiquinone) against a vehicle cream with no filters and no antioxidants, measuring mitochondrial DNA damage in real human facial skin for the first time.
- The antioxidant group showed roughly twofold better preservation of intact mitochondrial DNA, and 73.7 percent of that group improved versus 38.9 percent on the vehicle cream.
- Among people who already wore sunscreen daily, mitochondrial DNA integrity improved on the antioxidant formulation and actually got worse on the vehicle cream.
- The primary endpoint landed at P equals 0.06, just short of standard significance. It is a small, 41 person, industry funded pilot with no sunscreen only comparison arm, so it cannot separate what the antioxidants added from what the SPF alone did.
What twelve weeks of real sun exposure did to skin's mitochondria
A randomized, double blind, vehicle controlled trial run in the UK finally tested the idea in vivo. Adults applied either an encapsulated SPF 50 containing a multi antioxidant complex, resveratrol, glabridin, astaxanthin and ubiquinone, or an identical looking vehicle cream containing no UV filters and no antioxidants, once daily for 12 weeks through a UK spring. Cheek swabs taken at the start and at week 12 were assayed for mitochondrial DNA damage.
In the 41 participants who completed the trial, the antioxidant group showed a mean improvement in mitochondrial DNA integrity, while the vehicle group's skin got measurably worse. Because the underlying measurement is on a doubling scale, that gap works out to roughly twice as much intact mitochondrial DNA preserved in the antioxidant group. Looking at it a different way, 73.7 percent of people on the antioxidant formulation showed any improvement at all, compared with 38.9 percent on the vehicle cream. In a prespecified subgroup of people who already wore sunscreen every day before the trial started, the pattern held even more clearly: their mitochondrial DNA integrity improved on the antioxidant version and worsened on the vehicle.
Antioxidant sunscreen group
Showed any improvement in mitochondrial DNA integrity over the 12 week trial.
Vehicle cream group
No UV filters, no antioxidants. Fewer than four in ten improved.
41 completers in a 12 week, randomized, double blind UK trial. The primary endpoint itself landed at P equals 0.06, just short of the standard 0.05 significance threshold, which is why this is reported as promising rather than proven.
The number that keeps this promising, not proven
The headline result did not clear the conventional bar for statistical significance. The primary endpoint landed at P equals 0.06, just above the usual 0.05 threshold researchers use to call a result significant. The paper's authors lean on the responder rates, the subgroup analysis, and a Bayesian reframing of the same data to argue the effect is real, and they describe the study as a pilot with no formal sample size calculation going in. Just as important, the trial had no sunscreen only comparison arm, only the antioxidant formulation against a cream with neither filters nor antioxidants, so it genuinely cannot tell you how much of the benefit came from the SPF itself versus the antioxidants added on top. The authors say this was a manufacturing limitation of the specific formulation tested, not an oversight, but it is still the study's biggest structural gap.
Honest caveat
The primary endpoint did not reach statistical significance, at P equals 0.06, and this is a small, 41 person pilot study with no formal sample size calculation behind it. There was no sunscreen only comparison arm, so the trial cannot separate what the antioxidants contributed from what the SPF 50 base contributed on its own. The significant looking subgroup result rests on just 24 people. The outcome measured is a molecular biomarker, not visible skin appearance, so no conclusion follows here about wrinkles, pigmentation or how skin actually looks, and the study's own authors say so directly. There is also a real interest structure to name: the product was supplied and the lab processing was paid for by the company that makes it, whose founder is a co author, and the assay laboratory was founded and is co directed by other co authors on the paper. None of that makes the result false, but it is exactly why this should be read as preliminary, industry funded and worth watching, not as a settled finding.
resveratrol, glabridin, astaxanthin and ubiquinone, are a reasonable starting checklist
What this means for you
If you already wear sunscreen every day, which remains the single most well established thing you can do for your skin, this study is not a reason to panic about your current product or to rush out and replace it. What it adds is a genuinely new, if unproven, question worth watching: whether a sunscreen that also carries real antioxidants, at meaningful doses, does more for skin at the mitochondrial level than SPF protection alone. The four ingredients named in this trial, resveratrol, glabridin, astaxanthin and ubiquinone, are a reasonable starting checklist if you want to look for that combination on a label while the larger, better controlled trial the authors themselves call for gets run.
Primary sources
Common questions
Should I switch to an antioxidant sunscreen based on this study?
The direction of the result is promising, but the trial's primary endpoint did not reach standard statistical significance, and there was no sunscreen only comparison arm, so it cannot separate what the antioxidants added from what the SPF 50 itself did. This is genuinely worth watching, not yet a settled reason to switch products. The most important thing this study does confirm is that wearing sunscreen daily matters, since the vehicle only group's skin markers got worse over the 12 weeks.
Does regular sunscreen not already protect against this kind of damage?
UV filters block ultraviolet light, but they do not stop visible light, infrared light or pollution, all of which can still generate free radicals in skin. The theory behind adding antioxidants is that they mop up some of what the UV filters alone do not address. This trial is the first time that idea has been tested with a molecular marker in real living human skin, rather than in a lab dish.
Who funded this study, and does that matter?
The sunscreen was supplied and the lab processing was paid for by the company that makes it, whose founder is a co author, and the assay laboratory was founded and is co directed by other co authors on the paper. That interest structure does not make the result false, but it is exactly why the finding should be read as preliminary rather than proven, and why an independent, larger trial with a sunscreen only comparison group matters before drawing firm conclusions.
Stay Curious.
Better health isn't found in a single article. It's built through curiosity, evidence, and small discoveries over time. Join thousands exploring longevity, gut health, recovery, nutrition, and the tools that truly make a difference.